Clinical Microbiology Newsletter
Volume 31, Issue 8 , Pages 55-62 , 15 April 2009

Carbapenemases in Enterobacteriaceae: Activity, Epidemiology, and Laboratory Detection

  • Jean B. Patel, Ph.D.

      Affiliations

    • Corresponding Author InformationCorresponding Author: Jean B. Patel, PhD, D(ABMM), Leader, Antimicrobial Resistance Team, 1600 Clifton Rd. NE, Mailstop G08, Atlanta, GA 30333. Phone: 404-639-0361. Fax: 404-639-1381
    • ,
  • J. Kamile Rasheed, Ph.D.
    • ,
  • Brandon Kitchel, M.S.

References 

  1. Bradford PA , et al.   Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein . Antimicrob. Agents Chemother. . 1997;41:563–569
  2. Philippon A , Arlet Arlet , Jacoby GA . Plasmid-determined AmpC-type b-lactamases . Antimicrob. Agents Chemother. . 2002;46:1–11
  3. Cornaglia G , et al.   Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities . Antimicrob. Agents Chemother. . 1992;36:1902–1908
  4. Poirel L , et al.   In vivo acquisition of high-level resistance to imipenem in Escherichia coli . J. Clin. Microbiol. . 2004;42:3831–3833
  5. Crowley B , Benedí VJ , Doménech-Sánchez A . Expression of SHV-2 β-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems . Antimicrob. Agents Chemother. . 2002;46:3679–3682
  6. Livermore DM , Woodford N . The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter . Trends Microbiol. . 2006;14:413–420
  7. Woodford N , et al.   Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York medical center . Antimicrob. Agents Chemother. . 2004;48:4793–4799
  8. Bratu S , et al.   Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City . Arch. Intern. Med. . 2005;165:1430–1435
  9. Bradford PA , et al.   Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City . Clin. Infect. Dis. . 2004;39:55–60
  10. Queenan AM , Bush K . Carbapenemases: the versatile β-lactamases . Clin. Microbiol. Rev. . 2007;20:440–458
  11. Yigit H , et al.   Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae . Antimicrob. Agents Chemother. . 2001;45:1151–1161
  12. Yigit H , et al.   Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing β-lactamase KPC-2 . Antimicrob. Agents Chemother. . 2003;47:3881–3889
  13. Rasmussen BA , et al.   Characterization of IMI-1 β-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae . Antimicrob. Agents Chemother. . 1996;40:2080–2086
  14. Queenan AM , et al.   SME-type carbapenem-hydrolyzing class A β-lactamases from geographically diverse Serratia marcescens strains . Antimicrob. Agents Chemother. . 2000;44:3035–3039
  15. Naas T , et al.   Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A β-lactamase, Sme-1, from Serratia marcescens S6 . Antimicrob. Agents Chemother. . 1994;38:1262–1270
  16. Walther-Rasmussen J , Høiby N . Class A carbapenemases . J. Antimicrob. Chemother. . 2007;60:470–482
  17. Walsh TR . The emergence and implications of metallo-β-lactamases in gram-negative bacteria . Clin. Microbiol. Infect. . 2005;11:2–9
  18. Walsh TR , et al.   Metallo-β-lactamases: the quiet before the stormβ Clin . Microbiol. Rev. . 2005;18:306–325
  19. Walther-Rasmussen J , Høiby N . OXA-type carbapenemases . J. Antimicrob. Chemother. . 2006;57:373–383
  20. Lolans K , et al.   Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40 . Antimicrob. Agents Chemother. . 2006;50:2941–2945
  21. Perez F , et al.   Global challenge of multidrug-resistant Acinetobacter baumannii . Antimicrob. Agents Chemother. . 2007;51:3471–3484
  22. Poirel L , et al.   Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae . Antimicrob. Agents Chemother. . 2004;48:15–22
  23. Bonnet R , et al.   Chromosome-encoded class D β-lactamase OXA-23 in Proteus mirabilis . Antimicrob. Agents Chemother. . 2002;46:2004–2006
  24. Yigit H , et al.   Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae . Antimicrob. Agents Chemother. . 2008;52:809
  25. Robledo, I.E. et al. 2007. First report of a KPC-4 and CTX-M producing K. pneumoniae (Kp) isolated from Puerto Rico (PR), abstr. C2-1933, p. 142. In Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
  26. Alba J , et al.   Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing β-lactamase . Antimicrob. Agents Chemother. . 2005;49:4760–4762
  27. Bratu S , et al.   Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York . Clin. Infect. Dis. . 2007;44:972–975
  28. Miriagou V , et al.   Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2 . Antimicrob. Agents Chemother. . 2003;47:1297–1300
  29. Mushtaq S , Ge Ge , Livermore DM . Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized β-lactamases . Antimicrob. Agents Chemother. . 2004;48:1313–1319
  30. Villegas MV , et al.   First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America . Antimicrob. Agents Chemother. . 2006;50:2880–2882
  31. Deshpande LM , et al.   Emergence of serine carbapenemases (KPC and SME) among clinical strains of Entero bacteriaceae isolated in the United States Medical centers: report from the MYSTIC Program (1999-2005) . Diagn. Microbiol. Infect. Dis. . 2006;56:367–372
  32. Hong T , et al.   Escherichia coli: development of carbapenem resistance during therapy . Clin. Infect. Dis. . 2005;40:e84–e86
  33. Navon-Venezia S , et al.   Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel . Antimicrob. Agents Chemother. . 2006;50:3098–3101
  34. Villegas MV , et al.   First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase . Antimicrob. Agents Chemother. . 2007;51:1553–1555
  35. Bratu S , et al.   Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York . Antimicrob. Agents Chemother. . 2005;49:776–778
  36. Dortet L , et al.   Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1 . J. Antimicrob. Chemother. . 2008;61:455–457
  37. Wolter DJ , et al.   Detection of KPC carbapenem hydrolyzing β-lactamase in Pseudomonas aeruginosa (PA) from the Puerto Rico Medical Center Hospitals (PRMCHs), abstr. C2-1928 . In: Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother . Washington, DC: American Society for Microbiology; 2007;p. 141
  38. Chiang T , et al.   Identification of carbapenem-resistant Klebsiella pneumoniae harboring KPC enzymes in New Jersey . Microb. Drug Resist. . 2007;13:235–239
  39. Moland ES , et al.   Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates . J. Antimicrob. Chemother. . 2003;51:711–714
  40. Bratu S , et al.   Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection . Antimicrob. Agents Chemother. . 2005;49:3018–3020
  41. Della-Latta, P. and S. Jenkins, personal communication.
  42. Naas T , et al.   Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France . Antimicrob. Agents Chemother. . 2005;49:4423–4424
  43. Samra Z , et al.   Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int . J. Antimicrob. Agents . 2007;30:525–529
  44. Navon-Venezia S , et al.   Emergence of an epidemic clone of KPC-3 producing carbapenem-resistant Klebsiella pneumoniae (KPC Kpn) in Israel closely related to an epidemic clone in the United States, abstr. C2-1931 . In: Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother . Washington, DC: American Society for Microbiology; 2007;p. 141
  45. Wei Z-Q , et al.   Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China . Antimicrob. Agents Chemother. . 2007;51:763–765
  46. Cuzon G , et al.   Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece . Antimicrob. Agents Chemother. . 2008;52:796–797
  47. Monteiro J , et al.   Carbapenem-resistant Klebsiella pneumoniae outbreak: emergence of KPC-2 producing strains in Brazil, abstr. C2-1929 . In: Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother . Washington, DC: American Society for Microbiology; 2007;p. 141
  48. Hossain A , et al.   Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp . Antimicrob. Agents Chemother. . 2004;48:4438–4440
  49. Chmelnitsky I , et al.   Plasmid-mediated qnrB2 and carbapenemase gene blaKPC-2 carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates . Antimicrob. Agents Chemother. . 2008;52:2962–2965
  50. Rasheed JK , et al.   Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid . J. Clin Microbiol. . 2008;46:2066–2069
  51. Naas T , et al.   Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene . Antimicrob. Agents Chemother. . 2008;52:1257–1263
  52. Kitchel B , et al.   Molecular epidemiology of KPC-producing Klebsiella pneumoniae in the United States, abstr. C2-3730 . Abstr. 48th Ann. ICAAC/IDSA 46th Ann. Meet . Washington, DC: American Society for Microbiology; 2008;
  53. Naas T , Livermore DM , Nordmann P . Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing β-lactamase Sme-1, and comparison of this regulator with other β-lactamase regulators . Antimicrob. Agents Chemother. . 1995;39:629–637
  54. Naas T , Nordmann P . Analysis of a carbapenem-hydrolyzing class A β-lactamase from Enterobacter cloacae and its LysR-type regulatory protein . Proc. Natl. Acad. Sci. USA . 1994;91:7693–7697
  55. Nordmann P , et al.   Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli . Antimicrob. Agents Chemother. . 1993;37:939–946
  56. Rasmussen BA , Bush K . Carbapenem-hydrolyzing β-lactamases . Antimicrob. Agents Chemother. . 1997;41:223–232
  57. Aubron C , et al.   Carbapenemase-producing Enterobacteriaceae, U.S. rivers . Emerg. Infect. Dis. . 2005;11:260–264
  58. Yu Y-S , et al.   First isolation of blaIMI-2 in an Enterobacter cloacae clinical isolate from China . Antimicrob. Agents Chemother. . 2006;50:1610–1611
  59. Ploy MC , et al.   Integrons: an antibiotic resistance gene capture and expression system . Clin. Chem. Lab. Med. . 2000;38:483–487
  60. Senda K , et al.   PCR detection of metallo-b-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum b-lactams . J. Clin. Microbiol. . 1996;34:2909–2913
  61. Shibata N , et al.   PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron . J. Clin. Microbiol. . 2003;41:5407–5413
  62. Cornaglia G , et al.   Appearance of IMP-1 metallo-β-lactamase in Europe . Lancet . 1999;353:899–900
  63. Riccio ML , et al.   Characterization of the metallo-b-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny . Antimicrob. Agents Chemother. . 2000;44:1229–1235
  64. Hanson ND , et al.   First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-b-lactamase, IMP-18 . Antimicrob. Agents Chemother. . 2006;50:2272–2273
  65. Toleman MA , et al.   blaVIM-7, an evolutionarily distinct metallo-β-lactamase gene in a Pseudomonas aeruginosa isolate from the United States . Antimicrob. Agents Chemother. . 2004;48:329–332
  66. Lolans K , et al.   First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States . Antimicrob. Agents Chemother. . 2005;49:3538–3540
  67. Aboufaycal H , et al.   blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program . J. Clin. Microbiol. . 2007;45:614–615
  68. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI document M100-S18. CLSI, Wayne, PA.
  69. Anderson KF , et al.   Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae . J. Clin. Microbiol. . 2007;45:2723–2725
  70. Tenover FC , et al.   Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing . Emerg. Infect. Dis. . 2006;12:1209–1213
  71. Yan JJ , et al.   Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying blaIMP-8 in a university medical center in Taiwan . J. Clin. Microbiol. . 2001;39:4433–4439
  72. Tortola MT , et al.   First detection of a carbapenem-hydrolyzing metalloenzyme in two Enterobacteriaceae isolates in Spain . Antimicrob. Agents Chemother. . 2005;49:3492–3494
  73. Giakkoupi P , et al.   Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates . J. Clin. Microbiol. . 2005;43:494–496
  74. Petropoulou D , et al.   Evaluation of imipenem/imipenem+EDTA disk method for detection of metallo-β-lactamase-producing Klebsiella pneumoniae isolated from blood cultures . Microb. Drug Resist. . 2006;12:39–43
  75. Lee K , et al.   Modified Hodge and EDTA-disk synergy tests to screen metallo-b-lactamase-producing strains of Pseudomonas and Acinetobacter species . Clin. Microbiol. Infect. . 2001;7:88–91
  76. Hong SG , et al.   Indirect Tris-EDTA (TE) disk test for detection of class A carbapenemase in clinical isolates, abstr. D-448 . In: Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother . Washington, DC: American Society for Microbiology; 2006;p. 144
  77. Kim SY , et al.   Convenient test using a combination of chelating agents for detection of metallo-β-lactamases in the clinical laboratory . J. Clin. Microbiol. . 2007;45:2798–2801
  78. Yan JJ , et al.   Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative bacilli . Diagn. Microbiol. Infect. Dis. . 2004;49:5–11
  79. Arakawa Y , et al.   Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds . J. Clin. Microbiol. . 2000;38:40–43
  80. Walsh TR , et al.   Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing . J. Clin. Microbiol. . 2002;40:2755–2759
  81. Lee K , et al.   Evaluation of Etest MBL for detection of blaIMP-1 and blaVIM-2 allele-positive clinical isolates of Pseudomonas spp. and Acinetobacter spp . J. Clin. Microbiol. . 2005;43:942–944

 CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

PII: S0196-4399(09)00019-1

doi: 10.1016/j.clinmicnews.2009.03.005

Clinical Microbiology Newsletter
Volume 31, Issue 8 , Pages 55-62 , 15 April 2009

Article Tools

* Image Usage & Resolution